BR112017004919A2 - composto e seu uso, composição farmacêutica, método de inibição da síntese de nucleotídeos cíclicos e de ampc e gmpc em um paciente e método para tratamento profilático e/ou curativo - Google Patents
composto e seu uso, composição farmacêutica, método de inibição da síntese de nucleotídeos cíclicos e de ampc e gmpc em um paciente e método para tratamento profilático e/ou curativoInfo
- Publication number
- BR112017004919A2 BR112017004919A2 BR112017004919A BR112017004919A BR112017004919A2 BR 112017004919 A2 BR112017004919 A2 BR 112017004919A2 BR 112017004919 A BR112017004919 A BR 112017004919A BR 112017004919 A BR112017004919 A BR 112017004919A BR 112017004919 A2 BR112017004919 A2 BR 112017004919A2
- Authority
- BR
- Brazil
- Prior art keywords
- gmpc
- ampc
- prophylactic
- pharmaceutical composition
- curative treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
a presente invenção descreve novos compostos derivados de piridopirimidina com a estrutura representada pela fórmula geral (i): fórmula geral (i) ou seus sais farmaceuticamente aceitáveis, ou suas misturas (em qualquer proporção), uma composição farmacêutica contendo os mesmos, um método para utilização dos novos compostos derivados de piridopirimidina como inibidor da síntese de nucleotídeos cíclicos ou como inibidor da síntese de ampc e gmpc e seus usos no tratamento profilático e/ou curativo da diarréia, colite e síndrome do intestino irritável.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462049506P | 2014-09-12 | 2014-09-12 | |
PCT/BR2015/050147 WO2016037255A2 (en) | 2014-09-12 | 2015-09-11 | New pyridopyrimidines derivatives compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017004919A2 true BR112017004919A2 (pt) | 2017-12-12 |
Family
ID=55454107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017004919A BR112017004919A2 (pt) | 2014-09-12 | 2015-09-11 | composto e seu uso, composição farmacêutica, método de inibição da síntese de nucleotídeos cíclicos e de ampc e gmpc em um paciente e método para tratamento profilático e/ou curativo |
Country Status (18)
Country | Link |
---|---|
US (2) | US10280162B2 (pt) |
EP (1) | EP3191099B1 (pt) |
JP (1) | JP6661606B2 (pt) |
KR (1) | KR20170054408A (pt) |
CN (2) | CN107074847A (pt) |
AR (1) | AR101813A1 (pt) |
AU (1) | AU2015316120B2 (pt) |
BR (1) | BR112017004919A2 (pt) |
CA (1) | CA2958331C (pt) |
CL (1) | CL2017000582A1 (pt) |
CO (1) | CO2017001709A2 (pt) |
ES (1) | ES2701273T3 (pt) |
HU (1) | HUE040387T2 (pt) |
IL (1) | IL250968B (pt) |
MX (1) | MX2017003067A (pt) |
PL (1) | PL3191099T3 (pt) |
PT (1) | PT3191099T (pt) |
WO (1) | WO2016037255A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170204089A1 (en) | 2014-08-04 | 2017-07-20 | Drexel University | Novel compounds and methods of treating or ameliorating an il-1r-mediated disease or disorder using same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02012659A (es) | 2000-06-26 | 2003-09-22 | Lilly Icos Llc | Derivados de pirazindiona condensados. |
CN1275964C (zh) | 2000-08-31 | 2006-09-20 | 霍夫曼-拉罗奇有限公司 | 作为细胞增殖抑制剂的7-氧代吡啶并嘧啶 |
CA2427608C (en) * | 2000-11-08 | 2010-05-04 | Lilly Icos Llc | Condensed pyradizindione derivatives as pde inhibitors |
FR2896246B1 (fr) * | 2006-01-13 | 2008-08-15 | Sanofi Aventis Sa | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. |
DE602007006947D1 (de) * | 2006-05-23 | 2010-07-15 | Hoffmann La Roche | Pyridopyrimidinonderivate |
US20100035867A1 (en) * | 2006-07-11 | 2010-02-11 | Guerrant Richard L | Inhibitors of Cyclic Nucleotide Synthesis and Their Use for Therapy of Various Diseases |
US7474231B2 (en) * | 2006-07-12 | 2009-01-06 | Alcatel-Lucent Usa Inc. | Radio communications for vehicle speed adjustment |
UY33535A (es) * | 2010-08-13 | 2011-12-01 | Biolab Sanus Farmaceutuca Limitada | Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona |
US20150152101A1 (en) * | 2012-06-06 | 2015-06-04 | L'oreal | Active compounds for combating greasy skin |
-
2015
- 2015-09-11 EP EP15840871.6A patent/EP3191099B1/en active Active
- 2015-09-11 JP JP2017507425A patent/JP6661606B2/ja not_active Expired - Fee Related
- 2015-09-11 ES ES15840871T patent/ES2701273T3/es active Active
- 2015-09-11 BR BR112017004919A patent/BR112017004919A2/pt active Search and Examination
- 2015-09-11 WO PCT/BR2015/050147 patent/WO2016037255A2/en active Application Filing
- 2015-09-11 AR ARP150102896A patent/AR101813A1/es unknown
- 2015-09-11 HU HUE15840871A patent/HUE040387T2/hu unknown
- 2015-09-11 MX MX2017003067A patent/MX2017003067A/es active IP Right Grant
- 2015-09-11 PT PT15840871T patent/PT3191099T/pt unknown
- 2015-09-11 US US14/851,072 patent/US10280162B2/en active Active
- 2015-09-11 AU AU2015316120A patent/AU2015316120B2/en not_active Ceased
- 2015-09-11 CN CN201580048066.0A patent/CN107074847A/zh active Pending
- 2015-09-11 PL PL15840871T patent/PL3191099T3/pl unknown
- 2015-09-11 CA CA2958331A patent/CA2958331C/en active Active
- 2015-09-11 KR KR1020177007199A patent/KR20170054408A/ko active IP Right Grant
- 2015-09-11 CN CN202210592377.5A patent/CN114751905A/zh active Pending
-
2017
- 2017-02-22 CO CONC2017/0001709A patent/CO2017001709A2/es unknown
- 2017-03-06 IL IL250968A patent/IL250968B/en active IP Right Grant
- 2017-03-09 CL CL2017000582A patent/CL2017000582A1/es unknown
-
2019
- 2019-03-25 US US16/363,431 patent/US10822333B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20170054408A (ko) | 2017-05-17 |
CL2017000582A1 (es) | 2017-11-24 |
CN114751905A (zh) | 2022-07-15 |
AU2015316120B2 (en) | 2018-05-17 |
IL250968A0 (en) | 2017-04-30 |
CA2958331A1 (en) | 2016-03-17 |
WO2016037255A2 (en) | 2016-03-17 |
US20180111926A2 (en) | 2018-04-26 |
HUE040387T2 (hu) | 2019-03-28 |
AU2015316120A1 (en) | 2017-01-12 |
PT3191099T (pt) | 2018-12-18 |
CN107074847A (zh) | 2017-08-18 |
US10280162B2 (en) | 2019-05-07 |
CA2958331C (en) | 2019-12-17 |
EP3191099A2 (en) | 2017-07-19 |
US10822333B2 (en) | 2020-11-03 |
US20160075702A1 (en) | 2016-03-17 |
JP6661606B2 (ja) | 2020-03-11 |
WO2016037255A3 (en) | 2016-06-30 |
MX2017003067A (es) | 2017-06-14 |
IL250968B (en) | 2020-03-31 |
AR101813A1 (es) | 2017-01-11 |
PL3191099T3 (pl) | 2019-07-31 |
ES2701273T3 (es) | 2019-02-21 |
CO2017001709A2 (es) | 2017-03-31 |
EP3191099B1 (en) | 2018-11-14 |
JP2017526666A (ja) | 2017-09-14 |
US20190218216A1 (en) | 2019-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500904A1 (en) | Peptide macrocycles against acinetobacter baumannii | |
BR112017028504A2 (pt) | derivados de sulfamoilarilamida ciclizada e uso dos mesmos como medicamentos para o tratamento da hepatite b | |
BR112018070123A2 (pt) | oxiesterós e métodos de uso dos mesmos | |
BR112018070677A2 (pt) | inibidores de mcl-1 macrocíclicos para o tratamento de câncer | |
BR112017002811A2 (pt) | compostos de pirrolopirimidina usados como agonista de tlr7 | |
BR112018005497A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
BR112017010893A2 (pt) | análogos de ácidos biliares como agonistas de fxr/tgr5 e métodos de uso dos mesmos | |
BR112013026834A2 (pt) | composto, composição farmacêutica, produto farmacêutico de combinação, uso de um composto, e, método para tratar doenças ou condições e para inibir um bromodomínio | |
BR112016015983A2 (pt) | Compostos de indazol como inibidores de irak4, seus usos, e composição farmacêutica | |
BR112015003859A8 (pt) | Compostos de pirazolopirimidina como inibidores de quinase | |
BR112016018604A2 (pt) | Benzimidazol-2-aminas como inibidores de midh1 | |
BR112018003827A2 (pt) | composto, composição farmacêutica, combinação, uso de um composto, e, método para tratamento de uma doença ou condição. | |
BR112015026023A2 (pt) | derivados de 2- aminopirido[4,3-d]pirimidin-5-ona e seu uso como inibidores de wee-1 | |
BR112015015653A2 (pt) | derivados de azaindol como inibidores de quinases de proteínas | |
BR112017003346B8 (pt) | Derivados de pirazolopiridina, seus usos, e composição farmacêutica | |
BR112017004741A2 (pt) | compostos e composições como inibidores da raf quinase | |
BR112018067930A8 (pt) | Composto, sal de ácido trifluoroacético, composição farmacêutica, método para tratamento de uma infecção bacteriana, e, uso de um composto. | |
BR112017009012A2 (pt) | derivados de anel benzo de seis membros como inibidor de dpp-4 e seu uso | |
SA519402103B1 (ar) | 1,6-naphthyridine مشتقات 1، 6 نفثيرايدين CDK4/6 على شكل مثبط | |
BR112017023038A2 (pt) | imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa | |
BR112018070536A2 (pt) | composto, composição farmacêutica, combinação, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método de tratamento de uma doença ou condição | |
BR112018006545A2 (pt) | ?composto, composição farmacêutica, combinação, uso de um composto, e, método para tratamento de uma doença ou condição? | |
BR112016022342A8 (pt) | derivados de (5,6-di-hidro)pirimido[4,5-e] indolizinas, suas composições farmacêuticas, e seus usos | |
BR112017001334A2 (pt) | compostos de imidazopiridazina, seu uso e composição farmacêutica que os compreende | |
EA201792057A1 (ru) | Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |